INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT
The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process:wherein R1, R2, R3, R4, R6 and R10 are each as defined herein. The present invention also relates to processes for the preparation of these...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WINSHIP, Paul DRYSDALE, Martin CLARK, David BLAGG, Julian ROFFEY, Jon |
| description | The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process:wherein R1, R2, R3, R4, R6 and R10 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which MLH1 and/or PMS2 activity is implicated. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4157463A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4157463A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4157463A13</originalsourceid><addsrcrecordid>eNrjZDD29PPwdPIM8Q8KVvB3U_D18TBUcPRz0fcPUgjwDTZScAMynB39nF2DFEKCXB1DfF39QngYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgImhqbmJmbGjoTERSgAjoSZM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT</title><source>esp@cenet</source><creator>WINSHIP, Paul ; DRYSDALE, Martin ; CLARK, David ; BLAGG, Julian ; ROFFEY, Jon</creator><creatorcontrib>WINSHIP, Paul ; DRYSDALE, Martin ; CLARK, David ; BLAGG, Julian ; ROFFEY, Jon</creatorcontrib><description>The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process:wherein R1, R2, R3, R4, R6 and R10 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which MLH1 and/or PMS2 activity is implicated.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230405&DB=EPODOC&CC=EP&NR=4157463A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230405&DB=EPODOC&CC=EP&NR=4157463A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WINSHIP, Paul</creatorcontrib><creatorcontrib>DRYSDALE, Martin</creatorcontrib><creatorcontrib>CLARK, David</creatorcontrib><creatorcontrib>BLAGG, Julian</creatorcontrib><creatorcontrib>ROFFEY, Jon</creatorcontrib><title>INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT</title><description>The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process:wherein R1, R2, R3, R4, R6 and R10 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which MLH1 and/or PMS2 activity is implicated.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD29PPwdPIM8Q8KVvB3U_D18TBUcPRz0fcPUgjwDTZScAMynB39nF2DFEKCXB1DfF39QngYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgImhqbmJmbGjoTERSgAjoSZM</recordid><startdate>20230405</startdate><enddate>20230405</enddate><creator>WINSHIP, Paul</creator><creator>DRYSDALE, Martin</creator><creator>CLARK, David</creator><creator>BLAGG, Julian</creator><creator>ROFFEY, Jon</creator><scope>EVB</scope></search><sort><creationdate>20230405</creationdate><title>INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT</title><author>WINSHIP, Paul ; DRYSDALE, Martin ; CLARK, David ; BLAGG, Julian ; ROFFEY, Jon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4157463A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WINSHIP, Paul</creatorcontrib><creatorcontrib>DRYSDALE, Martin</creatorcontrib><creatorcontrib>CLARK, David</creatorcontrib><creatorcontrib>BLAGG, Julian</creatorcontrib><creatorcontrib>ROFFEY, Jon</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WINSHIP, Paul</au><au>DRYSDALE, Martin</au><au>CLARK, David</au><au>BLAGG, Julian</au><au>ROFFEY, Jon</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT</title><date>2023-04-05</date><risdate>2023</risdate><abstract>The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process:wherein R1, R2, R3, R4, R6 and R10 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which MLH1 and/or PMS2 activity is implicated.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4157463A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T17%3A41%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WINSHIP,%20Paul&rft.date=2023-04-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4157463A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |